The low treatment emergent anti-efzimfotase alfa ADA-positive rate and the absence of an apparent relationship between ADA positivity and efzimfotase alfa PK/PD further highlight the value of this ERT in the treatment of patients with HPP. Here, ADA is linked to hypophosphatasia.